Patterns of failure after the multimodality treatment of uterine papillary serous carcinoma

International Journal of Radiation Oncology Biology Physics

Volumn 57, Issue 1, 2003, Pages 208-216

  Sood, Brij M ^a,c   Jones, Joan ^b   Gupta, Sajel ^a   Khabele, Dineo ^b   Guha, Chandan ^a   Runowicz, Carol ^a   Goldberg, Gary ^b   Fields, Abbie ^b   Anderson, Patrick ^b   Vikram, B ^a  

^a INTERNATIONAL ATOMIC ENERGY AGENCY   (Austria)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c NY Hospital Medical Center of Queens   (United States)

Author keywords

Multimodality therapy; Patterns of failure; Uterine papillary serous carcinoma

Indexed keywords

DISEASES; PATHOLOGY; PATIENT TREATMENT; SURGERY; TUMORS;

SURGICAL TREATMENT;

ONCOLOGY;

CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; PACLITAXEL;

ABDOMINAL CANCER; ABDOMINAL HYSTERECTOMY; ADULT; AGED; ARTICLE; ASCITES FLUID CYTOLOGY; BEAM THERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER REGISTRY; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HOSPITAL; HUMAN; LAPAROTOMY; MEDICAL RECORD; METASTASIS; MULTIMODALITY CANCER THERAPY; PAPILLARY CARCINOMA; PARAAORTIC LYMPH NODE; PELVIS CANCER; PELVIS LYMPH NODE; PRIORITY JOURNAL; RADIATION DOSE; RANDOMIZATION; RETROSPECTIVE STUDY; SALPINGOOOPHORECTOMY; SAMPLING; STATISTICAL ANALYSIS; TREATMENT FAILURE; TREATMENT INDICATION; UTERUS CARCINOMA; VAGINA CANCER;

EID: 0042065289     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(03)00531-5     Document Type: Article

References (46)

1. Hendrickson M., Ross J., Eifel P., et al. Uterine papillary carcinoma A highly malignant form of endometrial adenocarcinoma . Am J Surg Pathol. 6:1982;93-108.
2. Lauchlan S.C. Tubal (serous) carcinoma of the endometrium. Arch Pathol Lab Med. 105:1981;615-618.
3. Dunton C.J., Balsara G., McFarland M., et al. Uterine papillary serous carcinoma A review . Obstet Gynecol Surv. 46:1991;97-102.
4. O'Hanlan K.A., Levine P.A., Harbatkin D., et al. Virulence of papillary endometrial carcinoma. Gynecol Oncol. 37:1990;112-119.
5. Ramirez-Gonzalez C.E., Adamsons K., Mangual-Vazquez T.Y., et al. Papillary adenocarcinoma in the endometrium. Obstet Gynecol. 70:1987;212-215.
6. Sherman M.E., Bitterman P., Rosenshein N.B., et al. Uterine serous carcinoma. A morphologically diverse neoplasm with unifying clinicopathologic features. Am J Surg Pathol. 16:1992;600-610.
7. Hendrickson M., Ross J., Eifel P.J., et al. Adenocarcinoma of the endometrium Analysis of 256 cases with carcinoma limited to the uterine corpus. Pathology review and analysis of prognostic variables . Gynecol Oncol. 13:1982;373-392.
8. Bancher-Todesca D., Neunteufel W., Williams K.E., et al. Influence of postoperative treatment on survival in patients with uterine papillary serous carcinoma. Gynecol Oncol. 71:1998;344-347.
9. Dembo A.J. The sequential multiple modality treatment of ovarian cancer. Radiother Oncol. 3:1985;187-192.
10. Abeler V.M., Kjorstad K.E. Serous papillary carcinoma of the endometrium A histopathological study of 22 cases . Gynecol Oncol. 39:1990;266-271.
11. Walker A.N., Mills S.E. Serous papillary carcinoma of the endometrium. A clinicopathologic study of 11 cases. Diagn Gynecol Obstet. 4:1982;261-267.
12. Goff B.A., Kato D., Rodney A.S., et al. Uterine papillary serous carcinoma Patterns of metastatic spread . Gynecol Oncol. 54:1994;264-268.
13. Piura B., Meirovitz M., Shmulman M., et al. Uterine papillary serous carcinoma: Study of 19 cases. Eur J Obstet Gynecol Reprod Biol. 79:1998;69-73.
14. Smith R.S., Kapp D.S., Chen Q., et al. Treatment of high-risk uterine cancer with whole abdominopelvic radiation therapy. Int J Radiat Oncol Biol Phys. 48:2000;767-778.
15. Christman J.E., Kapp D.S., Hendrickson M.R., et al. Therapeutic approaches to uterine papillary serous carcinoma A preliminary report . Gynecol Oncol. 26:1987;228-235.
16. Bristow R.E., Asrari F., Trimble E.L., et al. Extended surgical staging for uterine papillary serous carcinoma Survival outcome of locoregional (Stage I-III) disease . Gynecol Oncol. 81:2001;279-286.
17. Jeffrey J.F., Krepart G.V., Lotocki R.J. Papillary serous adenocarcinoma of the endometrium. Obstet Gynecol. 67:1986;670-674.
18. Sutton G.P., Brill L., Michael H., et al. Malignant papillary lesions of the endometrium. Gynecol Oncol. 27:1987;294-304.
19. Gallion H.H., van Nagell J.R. Jr., Powell D.F., et al. Stage I serous papillary carcinoma of the endometrium. Cancer. 63:1989;2224-2228.
20. Bristow R.E., Duska L.R., Montz F.J. The role of cytoreductive surgery in the management of stage IV uterine papillary serous carcinoma. Gynecol Oncol. 81:2001;92-99.
21. Gibbons S., Martinez A., Schray M., et al. Adjuvant whole abdominopelvic irradiation for high risk endometrial carcinoma. Int J Radiat Oncol Biol Phys. 21:1991;1019-1025.
22. Kato D.T., Ferry J.A., Goodman A., et al. Uterine papillary serous carcinoma (UPSC) A clinicopathologic study of 30 cases . Gynecol Oncol. 59:1995;384-389.
23. Grice J., Ek M., Greer B., et al. Uterine papillary serous carcinoma Evaluation of long-term survival in surgically staged patients . Gynecol Oncol. 69:1998;69-73.
24. Tay E.H., Ward B.G. The treatment of uterine papillary serous carcinoma (UPSC) Are we doing the right thing? Int J Gynecol Cancer. 9:1999;463-469.
25. Martinez A., Podratz K., Schray M., et al. Results of whole abdominopelvic irradiation with nodal boost for patients with endometrial cancer at high risk of failure in the peritoneal cavity. A prospective clinical trial at the Mayo Clinic. Hematol Oncol Clin North Am. 2:1988;431-446.
26. Martinez A., Schray M., Podratz K., et al. Postoperative whole abdomino-pelvic irradiation for patients with high risk endometrial cancer. Int J Radiat Oncol Biol Phys. 17:1989;371-377.
27. Nguyen N.P., Sallah S., Karlsson U., et al. Prognosis for papillary serous carcinoma of the endometrium after surgical staging. Int J Gynecol Cancer. 11:2001;305-311.
28. Creutzberg C.L., van Putten W.L., Koper P.C., et al. The morbidity of treatment for patients with Stage I endometrial cancer Results from a randomized trial . Int J Radiat Oncol Biol Phys. 51:2001;1246-1255.
29. Elliott P., Green D., Coates A., et al. The efficacy of postoperative vaginal irradiation in preventing vaginal recurrence in endometrial cancer. Int J Gynecol Cancer. 4:1994;84-93.
30. MacLeod C., Fowler A., Duval P., et al. High-dose-rate brachytherapy alone post-hysterectomy for endometrial cancer. Int J Radiat Oncol Biol Phys. 42:1998;1033-1039.
31. Roberts J., Brunetto V., Keys H. A phase III randomized study of surgery vs surgery plus adjunctive radiotherapy in intermediate-risk endometrial adenocarcinoma (GOG No.99). [Abstract] Gynecol Oncol. 68:1998;135.
32. Gejerman G, Katz AJ, Beitler J, et al. Vaginal apex recurrence in patients with early stage endometrial cancer treated by postoperative external beam RT without boost [Abstract]. Int J Radiat Oncol Biol Phys 1994;282(Suppl. 1):30.
33. Dembo A.J. Abdominopelvic radiotherapy in ovarian cancer. A 10-year experience. Cancer. 55:1985;2285-2290.
34. Dembo A.J. Epithelial ovarian cancer The role of radiotherapy . Int J Radiat Oncol Biol Phys. 22:1992;835-845.
35. Mallipeddi P., Kapp D.S., Teng N.N. Long-term survival with adjuvant whole abdominopelvic irradiation for uterine papillary serous carcinoma. Cancer. 71:1993;3076-3081.
36. Frank A.H., Tseng P.C., Haffty B.G., et al. Adjuvant whole-abdominal radiation therapy in uterine papillary serous carcinoma. Cancer. 68:1991;1516-1519.
37. Lim P., Al Kushi A., Gilks B., et al. Early stage uterine papillary serous carcinoma of the endometrium Effect of adjuvant whole abdominal radiotherapy and pathologic parameters on outcome . Cancer. 91:2001;752-757.
38. Memarzadeh S., Holschneider C.H., Bristow R.E., et al. FIGO stage III and IV uterine papillary serous carcinoma Impact of residual disease on survival . Int J Gynecol Cancer. 12:2002;454-458.
39. Fyles A.W., Thomas G.M., Pintilie M., et al. A randomized study of two doses of abdominopelvic radiation therapy for patients with optimally debulked Stage I, II, and III ovarian cancer. Int J Radiat Oncol Biol Phys. 41:1998;543-549.
40. Stringer C.A., Gershenson D.M., Burke T.W., et al. Adjuvant chemotherapy with cisplatin, doxorubicin, and cyclophosphamide (PAC) for early-stage high-risk endometrial cancer A preliminary analysis . Gynecol Oncol. 38:1990;305-308.
41. Levenback C., Burke T.W., Silva E., et al. Uterine papillary serous carcinoma (UPSC) treated with cisplatin, doxorubicin, and cyclophosphamide (PAC). Gynecol Oncol. 46:1992;317-321.
42. Price F.V., Chambers S.K., Carcangiu M.L., et al. Intravenous cisplatin, doxorubicin, and cyclophosphamide in the treatment of uterine papillary serous carcinoma (UPSC). Gynecol Oncol. 51:1993;383-389.
43. Chambers J.T., Chambers S.K., Kohorn E.I., et al. Uterine papillary serous carcinoma treated with intraperitoneal cisplatin and intravenous doxorubicin and cyclophosphamide. Gynecol Oncol. 60:1996;438-442.
44. Ramondetta L., Burke T.W., Levenback C., et al. Treatment of uterine papillary serous carcinoma with paclitaxel. Gynecol Oncol. 82:2001;156-161.
45. Zanotti K.M., Belinson J.L., Kennedy A.W., et al. The use of paclitaxel and platinum-based chemotherapy in uterine papillary serous carcinoma. Gynecol Oncol. 74:1999;272-277.
46. Nicklin J.L., Copeland L.J. Endometrial papillary serous carcinoma Patterns of spread and treatment . Clin Obstet Gynecol. 39:1996;686-695.